Table TDI-36. Primary amphetamine use among new clients entering treatment (%), 2003 to 2008

Country		2003	2004	2005	2006	2007	2008
Czech Republic		55.0	58.4	59.7	61.7	63.6	62.7
Denmark		10.4	12.9	10.2	14.9	13.5	14.2
Ireland		1.0	0.9	1.1	0.9	1.0	1.0
Latvia		14.0	24.5	22.6	22.3	24.0	24.5
Hungary	(1)	4.0	4.4	5.6	5.3	10.2	10.4
Netherlands		4.8	6.0	7.0	7.5	6.9	7.1
Slovakia		24.6	31.6	30.1	32.2	33.2	39.1
Finland		31.7	28.0	27.6	22.0	22.9	24.4
Sweden		30.7	27.7	32.7	33.0	27.7	24.8

Notes:

 Percentages are of new clients with known primary drug.               

 Only countries with available data are shown               

 (1) The source of the data has changed in 2007: from “Hungarian National Focal Point – National statistical programme” (1997-2006) to “Hungarian National Focal Point – TDI data collection” (2007). The change limits the comparability of the 2007 data to previous years data. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page.   

Sources:

 Reitox national reports 2009 — Standard table 34 See also Table TDI-4 and Table TDI-5 and see Table TDI-0] for details on sources.   

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)